STOCK TITAN

MACERICH CO (MAC) SEC Filings, May-Jun 2026

MAC NYSE
Rhea-AI Summary

Stephen Andrea M reported acquisition or exercise transactions in this Form 4 filing.

Macerich Company director Andrea M. Stephen received a non-cash equity award of 6,720 shares of Common Stock in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan. These restricted stock units vest one year after the award date.

After this grant and the inclusion of 3,413 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature, Stephen’s direct holdings total 104,921 shares of Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

LAING DIANA reported acquisition or exercise transactions in this Form 4 filing.

Macerich director Diana Laing received a non-cash grant of 6,720 restricted stock units under The Macerich Company 2003 Equity Incentive Plan. These units vest one year after the award date. Following the grant and including 625 dividend-equivalent units, she holds 163,291 common shares/units directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Lowenthal Marianne reported acquisition or exercise transactions in this Form 4 filing.

Macerich Company director Marianne Lowenthal received a grant of 6,720 shares of Common Stock as non-cash compensation. The award was in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan and carries a zero dollar grant price. The restricted stock units vest one year after the award date of 2026-06-01. Following this grant, Lowenthal directly holds 43,596 shares of Macerich common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Murphy Devin Ignatius reported acquisition or exercise transactions in this Form 4 filing.

MACERICH CO director Devin Ignatius Murphy reported a stock-based compensation grant rather than a market purchase. He received 6,720 shares of common stock in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan, at no cash cost, which vest one year after the award date. Following this grant, he holds 24,621 shares of common stock directly, including 414 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hirsch Daniel J. reported acquisition or exercise transactions in this Form 4 filing.

MACERICH CO director Daniel J. Hirsch received a non-cash award of 6,720 restricted stock units of Common Stock under The Macerich Company 2003 Equity Incentive Plan. These units vest one year after the award date. Following the award, he directly holds 91,898 shares and indirectly holds 4,732 shares through a family trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hash Steve reported acquisition or exercise transactions in this Form 4 filing.

MACERICH CO director Steve Hash received a grant of 9,520 shares of Common Stock as restricted stock units, awarded as non-cash compensation under The Macerich Company 2003 Equity Incentive Plan.

The restricted stock units vest one year after the award date. Following this grant and prior credited units, Hash now holds 156,153 shares directly, including 4,876 restricted stock units credited as dividend equivalents under the plan’s deferral feature.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

The Macerich Company filed an 8-K to furnish a new investor presentation updating its Path Forward Plan and long-term outlook. The deck highlights a Class A–focused mall portfolio, progress on deleveraging, and a substantial leasing and redevelopment pipeline intended to support future growth.

The Go-Forward Portfolio generated sales of $941 per square foot and averages seven annual visits per center, with roughly 90% of NOI coming from Class A properties. Management reports record leasing in 2025, an in-place Signed Not Open pipeline of about $120 million of incremental annual revenue and a goal of roughly $140 million. Pro forma leverage has been reduced by 1.5x from 8.76x at year-end 2023 to 7.76x net debt to EBITDA as of March 31, 2026, with a stated target of about 6.0x.

The presentation outlines illustrative 2028 Pro Forma NOI for the Go-Forward Portfolio in a range of $950–$990 million and a 2028 target FFO per share between $1.80 and $2.00, based on approximately 300 million shares. Macerich also notes about $1.3 billion of completed asset sales, a further $300–$400 million of anticipated 2026 dispositions, and a $900 million revolving credit facility contributing to roughly $1.2 billion of available liquidity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

The Macerich Company completed a common stock offering, issuing and selling 22,080,000 shares at a public offering price of $21.00 per share under an underwriting agreement with Goldman Sachs & Co. LLC and other underwriters. The underwriters’ 30-day option to purchase up to an additional 2,880,000 shares of common stock was exercised in full.

The company will contribute the net proceeds to The Macerich Partnership, L.P. in exchange for securities with economic interests similar to the common stock. The operating partnership intends to use the net proceeds to repay borrowings under the company’s revolving credit facility, which were used primarily to fund the acquisition of Annapolis Mall, and for general corporate purposes including acquiring additional properties and funding strategic leasing capital investments at Annapolis Mall, with any interim funds held in short-term, interest-bearing deposits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

The Macerich Company is offering $21.00 per share for 19,200,000 shares of common stock, with an underwriter option for an additional 2,880,000 shares. Proceeds will be contributed to the Operating Partnership and are intended principally to repay borrowings under the revolving credit facility and for general corporate purposes.

The offering is structured as a primary sale of common stock and the shares are expected to be delivered on or about May 13, 2026. The prospectus supplement discloses underwriting arrangements, lock‑ups, and international selling restrictions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

The Macerich Company is offering 16,000,000 shares of its common stock in a registered public offering, subject to completion. The prospectus supplement dated May 11, 2026 states the shares will be offered at a public offering price and that the underwriters have a 30-day option to purchase up to an additional 2,400,000 shares. The company says net proceeds are expected to be contributed to its Operating Partnership and used to repay borrowings under its revolving credit facility (which had $250.0 million outstanding as of May 8, 2026) and for general corporate purposes, including investments at Annapolis Mall.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.77%
Tags
prospectus

FAQ

How many MACERICH CO (MAC) SEC filings are available on StockTitan?

StockTitan tracks 63 SEC filings for MACERICH CO (MAC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for MACERICH CO (MAC)?

The most recent SEC filing for MACERICH CO (MAC) was filed on June 2, 2026.